id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT01967823
|
12:36:chronic_disease
|
Concurrent opportunistic infections
| 3
|
[
"Concurrent",
"opportunistic",
"infections"
] |
[
0,
2,
2
] |
NCT02338999
|
200:210:treatment
|
Significant impairment of major organ function (lung, heart, liver, kidney) or any condition that, in the opinion of the Investigator, would jeopardize the subject s safety following exposure to the study drug
| 3
|
[
"Significant",
"impairment",
"of",
"major",
"organ",
"function",
"(",
"lung",
",",
"heart",
",",
"liver",
",",
"kidney",
")",
"or",
"any",
"condition",
"that",
",",
"in",
"the",
"opinion",
"of",
"the",
"Investigator",
",",
"would",
"jeopardize",
"the",
"subject",
"s",
"safety",
"following",
"exposure",
"to",
"the",
"study",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02252432
|
1:22:chronic_disease,,
|
Chronic renal failure ( creatinine > 2.0 mg/dL)
| 3
|
[
"Chronic",
"renal",
"failure",
"(",
"creatinine",
">",
"2.0",
"mg/dL",
")"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02260258
|
12:43:treatment
|
Undergoing targeted temperature management
| 3
|
[
"Undergoing",
"targeted",
"temperature",
"management"
] |
[
0,
1,
1,
1
] |
NCT01954316
|
26:46:chronic_disease,50:67:chronic_disease,116:144:treatment,148:180:treatment
|
Patients with history of deep vein thrombosis or pulmonary embolus who are being treated with therapeutic doses of low molecular weight heparin or prophylactic dose anticoagulants may be enrolled
| 3
|
[
"Patients",
"with",
"history",
"of",
"deep",
"vein",
"thrombosis",
"or",
"pulmonary",
"embolus",
"who",
"are",
"being",
"treated",
"with",
"therapeutic",
"doses",
"of",
"low",
"molecular",
"weight",
"heparin",
"or",
"prophylactic",
"dose",
"anticoagulants",
"may",
"be",
"enrolled"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
1,
1,
1,
0,
0,
0
] |
NCT02488967
|
1:25:treatment
|
Sentinel lymphadenectomy alone
| 3
|
[
"Sentinel",
"lymphadenectomy",
"alone"
] |
[
1,
1,
0
] |
NCT02664909
|
12:32:chronic_disease
|
history of deep vein thrombosis
| 3
|
[
"history",
"of",
"deep",
"vein",
"thrombosis"
] |
[
0,
0,
2,
2,
2
] |
NCT02159495
|
38:57:treatment
|
Research participant must be off all anti-leukemic drugs
| 3
|
[
"Research",
"participant",
"must",
"be",
"off",
"all",
"anti-leukemic",
"drugs"
] |
[
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02000115
|
13:27:chronic_disease,39:55:chronic_disease,59:76:chronic_disease,,,166:186:chronic_disease,,,351:404:chronic_disease
|
Significant aortic disease, including abdominal aortic or thoracic aneurysm defined as maximal luminal diameter 5cm or greater; marked tortuosity (hyperacute bend), aortic arch atheroma (especially if thick [> 5 mm], protruding or ulcerated) or narrowing (especially with calcification and surface irregularities) of the abdominal or thoracic aorta, severe unfolding and tortuosity of the thoracic aorta (applicable for transfemoral patients only)
| 3
|
[
"Significant",
"aortic",
"disease",
",",
"including",
"abdominal",
"aortic",
"or",
"thoracic",
"aneurysm",
"defined",
"as",
"maximal",
"luminal",
"diameter",
"5cm",
"or",
"greater",
";",
"marked",
"tortuosity",
"(",
"hyperacute",
"bend",
")",
",",
"aortic",
"arch",
"atheroma",
"(",
"especially",
"if",
"thick",
"[",
">",
"5",
"mm",
"]",
",",
"protruding",
"or",
"ulcerated",
")",
"or",
"narrowing",
"(",
"especially",
"with",
"calcification",
"and",
"surface",
"irregularities",
")",
"of",
"the",
"abdominal",
"or",
"thoracic",
"aorta",
",",
"severe",
"unfolding",
"and",
"tortuosity",
"of",
"the",
"thoracic",
"aorta",
"(",
"applicable",
"for",
"transfemoral",
"patients",
"only",
")"
] |
[
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02172651
|
24:44:chronic_disease
|
History of symptomatic genitourinary stones within the past year
| 3
|
[
"History",
"of",
"symptomatic",
"genitourinary",
"stones",
"within",
"the",
"past",
"year"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02408861
|
1:13:treatment,
|
radiotherapy must be completed at least 4 weeks prior to registration
| 3
|
[
"radiotherapy",
"must",
"be",
"completed",
"at",
"least",
"4",
"weeks",
"prior",
"to",
"registration"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02146924
|
157:173:cancer
|
Research participants with confirmed 1st or higher relapse of disease by morphology, cytogenetics or molecular, or research participants with refractory or residual disease
| 3
|
[
"Research",
"participants",
"with",
"confirmed",
"1st",
"or",
"higher",
"relapse",
"of",
"disease",
"by",
"morphology",
",",
"cytogenetics",
"or",
"molecular",
",",
"or",
"research",
"participants",
"with",
"refractory",
"or",
"residual",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT02743728
|
1:9:cancer
|
Neoplasm
| 3
|
[
"Neoplasm"
] |
[
3
] |
NCT02578901
|
20:41:treatment,45:66:treatment,90:116:treatment,129:144:treatment,,
|
Subjects receiving anticoagulant therapy or anti-platelet therapy (except when receiving prophylactic anticoagulant or low dose aspirin therapy for prophylaxis only with a plan to discontinue when the platelet count falls below 50,000)
| 3
|
[
"Subjects",
"receiving",
"anticoagulant",
"therapy",
"or",
"anti-platelet",
"therapy",
"(",
"except",
"when",
"receiving",
"prophylactic",
"anticoagulant",
"or",
"low",
"dose",
"aspirin",
"therapy",
"for",
"prophylaxis",
"only",
"with",
"a",
"plan",
"to",
"discontinue",
"when",
"the",
"platelet",
"count",
"falls",
"below",
"50,000",
")"
] |
[
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02459119
|
44:59:treatment
|
Subject must be able to swallow and retain oral medication
| 3
|
[
"Subject",
"must",
"be",
"able",
"to",
"swallow",
"and",
"retain",
"oral",
"medication"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02485639
|
8:22:treatment,,60:77:treatment,87:116:treatment
|
taking anticoagulants, or long-term (greater than 14 days) systemic steroids or other immunosuppressive medications
| 3
|
[
"taking",
"anticoagulants",
",",
"or",
"long-term",
"(",
"greater",
"than",
"14",
"days",
")",
"systemic",
"steroids",
"or",
"other",
"immunosuppressive",
"medications"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1
] |
NCT01494662
|
5:31:treatment
|
Any prior treatment with T-DM1 for Cohorts 4A-4B
| 3
|
[
"Any",
"prior",
"treatment",
"with",
"T-DM1",
"for",
"Cohorts",
"4A-4B"
] |
[
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT01389024
|
,55:62:treatment
|
Pain crisis within two weeks requiring treatment with opiates
| 3
|
[
"Pain",
"crisis",
"within",
"two",
"weeks",
"requiring",
"treatment",
"with",
"opiates"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02572791
|
15:36:chronic_disease,
|
Patients with nosocomial infections (i.e., >48 hours after hospitalization)
| 3
|
[
"Patients",
"with",
"nosocomial",
"infections",
"(",
"i.e.",
",",
">",
"48",
"hours",
"after",
"hospitalization",
")"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03034811
|
1:22:chronic_disease
|
neuromuscular disease
| 3
|
[
"neuromuscular",
"disease"
] |
[
2,
2
] |
NCT02401347
|
24:42:chronic_disease,46:58:chronic_disease,76:103:chronic_disease
|
Clinically significant bleeding diathesis or coagulopathy, including known platelet function disorders
| 3
|
[
"Clinically",
"significant",
"bleeding",
"diathesis",
"or",
"coagulopathy",
",",
"including",
"known",
"platelet",
"function",
"disorders"
] |
[
0,
0,
2,
2,
0,
2,
0,
0,
0,
2,
2,
2
] |
NCT02486042
|
15:28:chronic_disease
|
Patients with liver disease as tested by LFTs
| 3
|
[
"Patients",
"with",
"liver",
"disease",
"as",
"tested",
"by",
"LFTs"
] |
[
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02261558
|
16:29:cancer,31:42:cancer,47:71:cancer
|
diagnosed with breast cancer, lung cancer, or gastro-intestinal cancer
| 3
|
[
"diagnosed",
"with",
"breast",
"cancer",
",",
"lung",
"cancer",
",",
"or",
"gastro-intestinal",
"cancer"
] |
[
0,
0,
3,
3,
0,
3,
3,
0,
0,
3,
3
] |
NCT01928576
|
38:56:treatment
|
Patients who are receiving any other anticancer therapy
| 3
|
[
"Patients",
"who",
"are",
"receiving",
"any",
"other",
"anticancer",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02857218
|
42:45:allergy_name
|
Subjects who have a contraindication for MRI
| 3
|
[
"Subjects",
"who",
"have",
"a",
"contraindication",
"for",
"MRI"
] |
[
0,
0,
0,
0,
0,
0,
4
] |
NCT02514915
|
25:28:treatment
|
No contraindications to MRI scanning with intravenous contrast
| 3
|
[
"No",
"contraindications",
"to",
"MRI",
"scanning",
"with",
"intravenous",
"contrast"
] |
[
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02954185
|
7:42:chronic_disease
|
Other orthopaedic conditions (spine/neck)
| 3
|
[
"Other",
"orthopaedic",
"conditions",
"(",
"spine/neck",
")"
] |
[
0,
2,
2,
2,
0,
0
] |
NCT02232516
|
1:31:cancer
|
T-cell prolymphocytic leukemia
| 3
|
[
"T-cell",
"prolymphocytic",
"leukemia"
] |
[
3,
3,
3
] |
NCT01908777
|
25:34:chronic_disease,46:61:treatment,72:105:chronic_disease,124:137:chronic_disease
|
Active and uncontrolled infection at time of transplantation including active infection with Aspergillus or other mold, or HIV infection
| 3
|
[
"Active",
"and",
"uncontrolled",
"infection",
"at",
"time",
"of",
"transplantation",
"including",
"active",
"infection",
"with",
"Aspergillus",
"or",
"other",
"mold",
",",
"or",
"HIV",
"infection"
] |
[
0,
0,
0,
2,
0,
0,
0,
1,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2
] |
NCT01952730
|
1:26:chronic_disease
|
Active autoimmune disease
| 3
|
[
"Active",
"autoimmune",
"disease"
] |
[
2,
2,
2
] |
NCT02871349
|
1:16:chronic_disease
|
Thyroid disease
| 3
|
[
"Thyroid",
"disease"
] |
[
2,
2
] |
NCT01389024
|
,,,58:61:treatment
|
Hemoglobin <6.5 g/dl (must be measured within 30 days of MRI)
| 3
|
[
"Hemoglobin",
"<",
"6.5",
"g/dl",
"(",
"must",
"be",
"measured",
"within",
"30",
"days",
"of",
"MRI",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02912572
|
7:41:chronic_disease,45:102:chronic_disease,141:166:treatment
|
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness, which may compromise the efficacy of immunostimulatory therapy
| 3
|
[
"Known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"or",
"acquired",
"immunodeficiency",
"syndrome",
"(",
"AIDS",
")",
"related",
"illness",
",",
"which",
"may",
"compromise",
"the",
"efficacy",
"of",
"immunostimulatory",
"therapy"
] |
[
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02189798
|
,69:81:chronic_disease
|
Duration greater than 30 years of severe-to-profound high-frequency hearing loss
| 3
|
[
"Duration",
"greater",
"than",
"30",
"years",
"of",
"severe-to-profound",
"high-frequency",
"hearing",
"loss"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01042522
|
,47:54:treatment,79:96:treatment,98:105:treatment,114:127:treatment
|
Patients must be entered within 8 weeks after surgery performed for either 1) initial diagnosis, staging, and/or cytoreduction, or 2) (if done) management of recurrent disease in a chemonaive patient
| 3
|
[
"Patients",
"must",
"be",
"entered",
"within",
"8",
"weeks",
"after",
"surgery",
"performed",
"for",
"either",
"1",
")",
"initial",
"diagnosis",
",",
"staging",
",",
"and/or",
"cytoreduction",
",",
"or",
"2",
")",
"(",
"if",
"done",
")",
"management",
"of",
"recurrent",
"disease",
"in",
"a",
"chemonaive",
"patient"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02350764
|
,,,,,185:195:treatment
|
Women of childbearing potential (WOCBP) must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG) within 3 days prior to the start of study drug
| 3
|
[
"Women",
"of",
"childbearing",
"potential",
"(",
"WOCBP",
")",
"must",
"have",
"a",
"negative",
"serum",
"or",
"urine",
"pregnancy",
"test",
"(",
"minimum",
"sensitivity",
"25",
"IU/L",
"or",
"equivalent",
"units",
"of",
"HCG",
")",
"within",
"3",
"days",
"prior",
"to",
"the",
"start",
"of",
"study",
"drug"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02558972
|
1:4:chronic_disease,,,
|
VVS (fainting) subjects will have at least 2 episodes of postural VVS during the past calendar year
| 3
|
[
"VVS",
"(",
"fainting",
")",
"subjects",
"will",
"have",
"at",
"least",
"2",
"episodes",
"of",
"postural",
"VVS",
"during",
"the",
"past",
"calendar",
"year"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01925131
|
1:51:treatment,
|
previous treatment with other anti-CD22 antibodies must have been completed at least 90 days prior to registration
| 3
|
[
"previous",
"treatment",
"with",
"other",
"anti-CD22",
"antibodies",
"must",
"have",
"been",
"completed",
"at",
"least",
"90",
"days",
"prior",
"to",
"registration"
] |
[
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01626079
|
1:18:treatment,31:48:cancer,50:58:chronic_disease,62:72:chronic_disease
|
Echocardiographic evidence of intracardiac mass, thrombus or vegetation
| 3
|
[
"Echocardiographic",
"evidence",
"of",
"intracardiac",
"mass",
",",
"thrombus",
"or",
"vegetation"
] |
[
1,
0,
0,
3,
3,
0,
2,
0,
2
] |
NCT02573246
|
44:52:chronic_disease
|
Current serious medical illness, including migraine headaches
| 3
|
[
"Current",
"serious",
"medical",
"illness",
",",
"including",
"migraine",
"headaches"
] |
[
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02204098
|
1:11:treatment
|
Biotherapy
| 3
|
[
"Biotherapy"
] |
[
1
] |
NCT02867124
|
12:27:chronic_disease
|
History of opiate disorder [meeting DSM-V criteria of dependence at the time of incarceration]
| 3
|
[
"History",
"of",
"opiate",
"disorder",
"[",
"meeting",
"DSM-V",
"criteria",
"of",
"dependence",
"at",
"the",
"time",
"of",
"incarceration",
"]"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02412540
|
17:30:chronic_disease
|
Non-compensated liver disease with any of the following
| 3
|
[
"Non-compensated",
"liver",
"disease",
"with",
"any",
"of",
"the",
"following"
] |
[
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02503722
|
25:50:chronic_disease,52:90:chronic_disease,92:113:chronic_disease,129:146:treatment
|
Past medical history of interstitial lung disease, drug-induced interstitial lung disease, radiation pneumonitis which required steroid treatment, or any evidence of clinically active interstitial lung disease
| 3
|
[
"Past",
"medical",
"history",
"of",
"interstitial",
"lung",
"disease",
",",
"drug-induced",
"interstitial",
"lung",
"disease",
",",
"radiation",
"pneumonitis",
"which",
"required",
"steroid",
"treatment",
",",
"or",
"any",
"evidence",
"of",
"clinically",
"active",
"interstitial",
"lung",
"disease"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
2,
2,
0,
2,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01532687
|
1:37:treatment
|
Coronary artery bypass graft surgery
| 3
|
[
"Coronary",
"artery",
"bypass",
"graft",
"surgery"
] |
[
1,
1,
1,
1,
1
] |
NCT02088554
|
33:48:chronic_disease,135:179:treatment,197:219:chronic_disease
|
Patient has moderate or greater aortic stenosis or regurgitation, and there is clinical indication for replacement of their native or prosthetic aortic valve with a bioprosthesis, with or without concomitant procedures
| 3
|
[
"Patient",
"has",
"moderate",
"or",
"greater",
"aortic",
"stenosis",
"or",
"regurgitation",
",",
"and",
"there",
"is",
"clinical",
"indication",
"for",
"replacement",
"of",
"their",
"native",
"or",
"prosthetic",
"aortic",
"valve",
"with",
"a",
"bioprosthesis",
",",
"with",
"or",
"without",
"concomitant",
"procedures"
] |
[
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
2,
2
] |
NCT03065972
|
3:20:chronic_disease
|
a bleeding disorder
| 3
|
[
"a",
"bleeding",
"disorder"
] |
[
0,
2,
2
] |
NCT02570984
|
1:33:treatment,44:53:treatment,64:72:treatment
|
Prior aeroallergen immunotherapy or use of biologics including anti-IgE
| 3
|
[
"Prior",
"aeroallergen",
"immunotherapy",
"or",
"use",
"of",
"biologics",
"including",
"anti-IgE"
] |
[
1,
1,
1,
0,
0,
0,
1,
0,
1
] |
NCT02561988
|
1:4:cancer
|
MCL
| 3
|
[
"MCL"
] |
[
3
] |
NCT02473250
|
31:41:treatment,42:53:treatment,57:68:treatment,76:91:treatment,93:102:treatment,104:115:treatment,119:126:treatment
|
Subject is likely to tolerate medication cross-taper to monotherapy with a mood stabilizer (valproate, lamotrigine or lithium)
| 3
|
[
"Subject",
"is",
"likely",
"to",
"tolerate",
"medication",
"cross-taper",
"to",
"monotherapy",
"with",
"a",
"mood",
"stabilizer",
"(",
"valproate",
",",
"lamotrigine",
"or",
"lithium",
")"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT01280669
|
1:31:chronic_disease
|
Ocular or periocular infection in either eye
| 3
|
[
"Ocular",
"or",
"periocular",
"infection",
"in",
"either",
"eye"
] |
[
2,
2,
2,
2,
0,
0,
0
] |
NCT02535832
|
1:12:cancer
|
skin cancer
| 3
|
[
"skin",
"cancer"
] |
[
3,
3
] |
NCT02920086
|
1:26:treatment
|
Renal replacement therapy
| 3
|
[
"Renal",
"replacement",
"therapy"
] |
[
1,
1,
1
] |
NCT02535312
|
,46:56:treatment
|
>= 45 ml/min/1.73 m^2 for patients receiving pemetrexed
| 3
|
[
">",
"=",
"45",
"ml/min/1.73",
"m^2",
"for",
"patients",
"receiving",
"pemetrexed"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02547818
|
43:65:treatment
|
Must provide written informed consent for APOe4 genotype testing
| 3
|
[
"Must",
"provide",
"written",
"informed",
"consent",
"for",
"APOe4",
"genotype",
"testing"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02067819
|
1:5:chronic_disease
|
Tics are of at least moderate clinical severity as evidenced by a Yale Global Tic Severity
| 3
|
[
"Tics",
"are",
"of",
"at",
"least",
"moderate",
"clinical",
"severity",
"as",
"evidenced",
"by",
"a",
"Yale",
"Global",
"Tic",
"Severity"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02459119
|
1:14:treatment,24:40:treatment,42:54:treatment,58:74:treatment,
|
Prior therapy with any systemic therapy (chemotherapy or biologic therapy) within twenty-eight days prior to study entry
| 3
|
[
"Prior",
"therapy",
"with",
"any",
"systemic",
"therapy",
"(",
"chemotherapy",
"or",
"biologic",
"therapy",
")",
"within",
"twenty-eight",
"days",
"prior",
"to",
"study",
"entry"
] |
[
1,
1,
0,
0,
1,
1,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03055377
|
27:43:allergy_name
|
Allergy or intolerance to N-acetylcysteine
| 3
|
[
"Allergy",
"or",
"intolerance",
"to",
"N-acetylcysteine"
] |
[
0,
0,
0,
0,
4
] |
NCT02013492
|
23:35:treatment,39:51:treatment,,,80:92:treatment,96:107:treatment,
|
Patients who have had chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) prior to entering the study or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier
| 3
|
[
"Patients",
"who",
"have",
"had",
"chemotherapy",
"or",
"radiotherapy",
"within",
"4",
"weeks",
"(",
"6",
"weeks",
"for",
"nitrosoureas",
"or",
"mitomycin",
"C",
")",
"prior",
"to",
"entering",
"the",
"study",
"or",
"those",
"who",
"have",
"not",
"recovered",
"from",
"adverse",
"events",
"due",
"to",
"agents",
"administered",
"more",
"than",
"4",
"weeks",
"earlier"
] |
[
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02593110
|
8:26:chronic_disease,,
|
Severe hepatic impairment defined by two or more liver function enzyme values greater than 2.5 the upper limit of normal
| 3
|
[
"Severe",
"hepatic",
"impairment",
"defined",
"by",
"two",
"or",
"more",
"liver",
"function",
"enzyme",
"values",
"greater",
"than",
"2.5",
"the",
"upper",
"limit",
"of",
"normal"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03091790
|
1:17:chronic_disease
|
Active infection
| 3
|
[
"Active",
"infection"
] |
[
2,
2
] |
NCT00715611
|
1:42:cancer
|
Epithelioid or biphasic histology subtype
| 3
|
[
"Epithelioid",
"or",
"biphasic",
"histology",
"subtype"
] |
[
3,
3,
3,
3,
3
] |
NCT02243631
|
12:24:chronic_disease
|
History of renal stones
| 3
|
[
"History",
"of",
"renal",
"stones"
] |
[
0,
0,
2,
2
] |
NCT01901562
|
21:50:cancer,54:64:treatment,66:77:treatment,85:95:treatment
|
Have diagnosed with multiple or sessile papilloma by ultrasound, mammography and/or ductoscopy
| 3
|
[
"Have",
"diagnosed",
"with",
"multiple",
"or",
"sessile",
"papilloma",
"by",
"ultrasound",
",",
"mammography",
"and/or",
"ductoscopy"
] |
[
0,
0,
0,
3,
3,
3,
3,
0,
1,
0,
1,
0,
1
] |
NCT02504866
|
56:73:treatment,75:96:treatment,98:128:treatment,130:138:treatment,142:153:treatment,155:183:treatment,185:199:treatment,274:278:treatment,282:291:treatment,293:298:treatment,300:304:treatment,306:311:treatment,313:325:treatment,329:345:treatment,347:353:treatment,355:379:treatment,381:389:treatment
|
Have metal that would make an MRI scan unsafe such as: cardiac pacemaker, insulin infusion pump, implanted drug infusion devise, cochlear or ear implant, transdermal medication patch (nitroglycerine), any metallic implants or objects, body piercing that cannot be removed, bone or joint pin, screw, nail, plate, wire sutures or surgical staples, shunts, cerebral aneurysms clips, shrapnel or other metal embedded (such as from war wounds or accidents or previous work in metal fields or machines that may have left any metallic fragments in or near your eyes)
| 3
|
[
"Have",
"metal",
"that",
"would",
"make",
"an",
"MRI",
"scan",
"unsafe",
"such",
"as",
":",
"cardiac",
"pacemaker",
",",
"insulin",
"infusion",
"pump",
",",
"implanted",
"drug",
"infusion",
"devise",
",",
"cochlear",
"or",
"ear",
"implant",
",",
"transdermal",
"medication",
"patch",
"(",
"nitroglycerine",
")",
",",
"any",
"metallic",
"implants",
"or",
"objects",
",",
"body",
"piercing",
"that",
"can",
"not",
"be",
"removed",
",",
"bone",
"or",
"joint",
"pin",
",",
"screw",
",",
"nail",
",",
"plate",
",",
"wire",
"sutures",
"or",
"surgical",
"staples",
",",
"shunts",
",",
"cerebral",
"aneurysms",
"clips",
",",
"shrapnel",
"or",
"other",
"metal",
"embedded",
"(",
"such",
"as",
"from",
"war",
"wounds",
"or",
"accidents",
"or",
"previous",
"work",
"in",
"metal",
"fields",
"or",
"machines",
"that",
"may",
"have",
"left",
"any",
"metallic",
"fragments",
"in",
"or",
"near",
"your",
"eyes",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
1,
1,
1,
1,
0,
1,
0,
1,
1,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
1,
0,
1,
0,
1,
0,
1,
1,
0,
1,
1,
0,
1,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02614365
|
55:70:treatment,72:87:treatment,89:114:treatment,116:127:treatment,130:148:treatment,157:172:treatment,174:183:treatment
|
Medications with significant effect on memory such as anticholinergic (diphenhydramine, tricyclic antidepressants, benztropine); sedative hypnotics such as benzodiazepines; narcotics; and antiparkinsonian medications will all be excluded
| 3
|
[
"Medications",
"with",
"significant",
"effect",
"on",
"memory",
"such",
"as",
"anticholinergic",
"(",
"diphenhydramine",
",",
"tricyclic",
"antidepressants",
",",
"benztropine",
")",
";",
"sedative",
"hypnotics",
"such",
"as",
"benzodiazepines",
";",
"narcotics",
";",
"and",
"antiparkinsonian",
"medications",
"will",
"all",
"be",
"excluded"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
1,
0,
1,
0,
0,
1,
1,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01959204
|
,142:152:treatment
|
Had a clinically significant illness, except for the condition for which the procedure is being performed, in the 28 days before dosing with study drug as determined by the clinical investigator
| 3
|
[
"Had",
"a",
"clinically",
"significant",
"illness",
",",
"except",
"for",
"the",
"condition",
"for",
"which",
"the",
"procedure",
"is",
"being",
"performed",
",",
"in",
"the",
"28",
"days",
"before",
"dosing",
"with",
"study",
"drug",
"as",
"determined",
"by",
"the",
"clinical",
"investigator"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02133196
|
,49:65:treatment,76:107:chronic_disease,145:164:treatment
|
More than two weeks must have elapsed since any prior palliation for major bronchial occlusion or bleeding at the time the patient receives the preparative regimen
| 3
|
[
"More",
"than",
"two",
"weeks",
"must",
"have",
"elapsed",
"since",
"any",
"prior",
"palliation",
"for",
"major",
"bronchial",
"occlusion",
"or",
"bleeding",
"at",
"the",
"time",
"the",
"patient",
"receives",
"the",
"preparative",
"regimen"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03060473
|
1:8:chronic_disease
|
abscess
| 3
|
[
"abscess"
] |
[
2
] |
NCT00001651
|
1:20:chronic_disease
|
Psychiatric illness or disturbance which, in the assessment of the protocol team, may affect patient safety or compliance
| 3
|
[
"Psychiatric",
"illness",
"or",
"disturbance",
"which",
",",
"in",
"the",
"assessment",
"of",
"the",
"protocol",
"team",
",",
"may",
"affect",
"patient",
"safety",
"or",
"compliance"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02311361
|
25:53:treatment,,94:102:treatment,107:119:treatment
|
Current or prior use of immunosuppressive medication within 14 days before the first dose of MEDI4736 and tremelimumab
| 3
|
[
"Current",
"or",
"prior",
"use",
"of",
"immunosuppressive",
"medication",
"within",
"14",
"days",
"before",
"the",
"first",
"dose",
"of",
"MEDI4736",
"and",
"tremelimumab"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT02003222
|
18:31:cancer
|
New diagnosis of B lineage ALL must be made upon bone marrow or peripheral blood immunophenotyping; cases with myeloid antigen expression, but unequivocal lymphoid immunophenotype
| 3
|
[
"New",
"diagnosis",
"of",
"B",
"lineage",
"ALL",
"must",
"be",
"made",
"upon",
"bone",
"marrow",
"or",
"peripheral",
"blood",
"immunophenotyping",
";",
"cases",
"with",
"myeloid",
"antigen",
"expression",
",",
"but",
"unequivocal",
"lymphoid",
"immunophenotype"
] |
[
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02531295
|
1:71:treatment,,,
|
Continuous therapy with a DHHS recommended/alternative combination ART for least 36 months (at least 3 agents) at study entry with no regimen changes in the preceding 24 weeks
| 3
|
[
"Continuous",
"therapy",
"with",
"a",
"DHHS",
"recommended/alternative",
"combination",
"ART",
"for",
"least",
"36",
"months",
"(",
"at",
"least",
"3",
"agents",
")",
"at",
"study",
"entry",
"with",
"no",
"regimen",
"changes",
"in",
"the",
"preceding",
"24",
"weeks"
] |
[
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02703220
|
1:17:chronic_disease
|
Seizure disorder
| 3
|
[
"Seizure",
"disorder"
] |
[
2,
2
] |
NCT02172651
|
20:48:cancer,50:73:cancer,78:113:cancer,134:149:cancer
|
Curatively treated non-melanoma skin malignancy, cervical cancer in situ, or prostatic intraepithelial neoplasia without evidence of prostate cancer
| 3
|
[
"Curatively",
"treated",
"non-melanoma",
"skin",
"malignancy",
",",
"cervical",
"cancer",
"in",
"situ",
",",
"or",
"prostatic",
"intraepithelial",
"neoplasia",
"without",
"evidence",
"of",
"prostate",
"cancer"
] |
[
0,
0,
3,
3,
3,
0,
3,
3,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
3,
3
] |
NCT02744677
|
68:80:treatment
|
Inappropriate anatomy for femoral introduction and delivery of the SAPIEN 3 THV
| 3
|
[
"Inappropriate",
"anatomy",
"for",
"femoral",
"introduction",
"and",
"delivery",
"of",
"the",
"SAPIEN",
"3",
"THV"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02543983
|
13:20:chronic_disease
|
No lifetime suicide attempts or ideations
| 3
|
[
"No",
"lifetime",
"suicide",
"attempts",
"or",
"ideations"
] |
[
0,
0,
2,
0,
0,
0
] |
NCT02964182
|
45:62:chronic_disease
|
Self report of past or current diagnosis of bi-polar disorder
| 3
|
[
"Self",
"report",
"of",
"past",
"or",
"current",
"diagnosis",
"of",
"bi-polar",
"disorder"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02739620
|
1:30:treatment
|
prior knee or hip replacement
| 3
|
[
"prior",
"knee",
"or",
"hip",
"replacement"
] |
[
1,
1,
1,
1,
1
] |
NCT01659541
|
11:15:chronic_disease,17:31:chronic_disease,35:48:chronic_disease
|
Untreated lung, cardiovascular or brain disease
| 3
|
[
"Untreated",
"lung",
",",
"cardiovascular",
"or",
"brain",
"disease"
] |
[
0,
2,
0,
2,
0,
2,
2
] |
NCT02607748
|
1:30:chronic_disease,,166:172:chronic_disease,186:195:treatment,210:231:chronic_disease,235:261:treatment
|
Stable Ischemic Heart Disease group: 40 patients who have undergone invasive coronary angiography within 21 days prior to the imaging visit, with history of typical angina prior to the angiogram, but no prior myocardial infarction or coronary revascularization
| 3
|
[
"Stable",
"Ischemic",
"Heart",
"Disease",
"group",
":",
"40",
"patients",
"who",
"have",
"undergone",
"invasive",
"coronary",
"angiography",
"within",
"21",
"days",
"prior",
"to",
"the",
"imaging",
"visit",
",",
"with",
"history",
"of",
"typical",
"angina",
"prior",
"to",
"the",
"angiogram",
",",
"but",
"no",
"prior",
"myocardial",
"infarction",
"or",
"coronary",
"revascularization"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
1,
0,
0,
0,
0,
2,
2,
0,
0,
0
] |
NCT02943109
|
9:14:chronic_disease
|
legally blind
| 3
|
[
"legally",
"blind"
] |
[
0,
2
] |
NCT01972919
|
,,41:52:treatment,
|
Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve Hgb ≥ 8.0 g/dl is acceptable.)
| 3
|
[
"Hemoglobin",
"≥",
"8.0",
"g/dl",
"(",
"Note",
":",
"The",
"use",
"of",
"transfusion",
"or",
"other",
"intervention",
"to",
"achieve",
"Hgb",
"≥",
"8.0",
"g/dl",
"is",
"acceptable",
".",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01804634
|
11:22:cancer,17:22:cancer,27:46:cancer,39:46:cancer,
|
Any other solid tumor and soft tissue sarcoma with an estimated <10% chance of survival will be considered on a case by case basis at the departmental tumor board and/or sarcoma meeting
| 3
|
[
"Any",
"other",
"solid",
"tumor",
"and",
"soft",
"tissue",
"sarcoma",
"with",
"an",
"estimated",
"<",
"10",
"%",
"chance",
"of",
"survival",
"will",
"be",
"considered",
"on",
"a",
"case",
"by",
"case",
"basis",
"at",
"the",
"departmental",
"tumor",
"board",
"and/or",
"sarcoma",
"meeting"
] |
[
0,
0,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01581580
|
15:30:chronic_disease
|
Additional or isolated tremor in head may be present but there should be the absence of abnormal posturing)
| 3
|
[
"Additional",
"or",
"isolated",
"tremor",
"in",
"head",
"may",
"be",
"present",
"but",
"there",
"should",
"be",
"the",
"absence",
"of",
"abnormal",
"posturing",
")"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02466750
|
28:51:treatment,
|
medical history (including concomitant medications) within 60 days of planned first administration of vaccine
| 3
|
[
"medical",
"history",
"(",
"including",
"concomitant",
"medications",
")",
"within",
"60",
"days",
"of",
"planned",
"first",
"administration",
"of",
"vaccine"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02574728
|
23:41:treatment
|
who are refractory to front-line therapy
| 3
|
[
"who",
"are",
"refractory",
"to",
"front-line",
"therapy"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT01776190
|
32:47:chronic_disease
|
You do not have a diagnosis of cutaneous lupus
| 3
|
[
"You",
"do",
"not",
"have",
"a",
"diagnosis",
"of",
"cutaneous",
"lupus"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02047474
|
4:105:treatment
|
No prior treatment with oxaliplatin, irinotecan (irinotecan hydrochloride), fluorouracil or capecitabine
| 3
|
[
"No",
"prior",
"treatment",
"with",
"oxaliplatin",
",",
"irinotecan",
"(",
"irinotecan",
"hydrochloride",
")",
",",
"fluorouracil",
"or",
"capecitabine"
] |
[
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0
] |
NCT01715571
|
24:30:chronic_disease
|
Penile skin lesions or ulcers
| 3
|
[
"Penile",
"skin",
"lesions",
"or",
"ulcers"
] |
[
0,
0,
0,
0,
2
] |
NCT02276716
|
45:66:treatment
|
Patients who are currently participating in other clinical trials of compounds that my change IKAP gene expression
| 3
|
[
"Patients",
"who",
"are",
"currently",
"participating",
"in",
"other",
"clinical",
"trials",
"of",
"compounds",
"that",
"my",
"change",
"IKAP",
"gene",
"expression"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03123055
|
15:33:chronic_disease,,,108:118:treatment,147:176:treatment,198:232:treatment,
|
Patients with autoimmune disease or medical conditions that required systemic corticosteroids (> 10 mg/day prednisone or its equivalent) or other immunosuppressive medications or any other form of systemic immunosuppressive therapy within 7 days prior to the first dose of study treatment
| 3
|
[
"Patients",
"with",
"autoimmune",
"disease",
"or",
"medical",
"conditions",
"that",
"required",
"systemic",
"corticosteroids",
"(",
">",
"10",
"mg/day",
"prednisone",
"or",
"its",
"equivalent",
")",
"or",
"other",
"immunosuppressive",
"medications",
"or",
"any",
"other",
"form",
"of",
"systemic",
"immunosuppressive",
"therapy",
"within",
"7",
"days",
"prior",
"to",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00914628
|
1:14:cancer
|
secondary AML in CR
| 3
|
[
"secondary",
"AML",
"in",
"CR"
] |
[
3,
3,
0,
0
] |
NCT02178566
|
12:27:chronic_disease
|
History of pulmonary edema
| 3
|
[
"History",
"of",
"pulmonary",
"edema"
] |
[
0,
0,
2,
2
] |
NCT02064296
|
13:25:chronic_disease,43:56:chronic_disease,79:117:chronic_disease,119:144:chronic_disease,149:179:chronic_disease
|
Do not have fibromyalgia or an associated pain disorder, including: migraine, temporomandibular joint disorder (TMJ), chronic pelvic pain (CPP), or chronic fatigue syndrome (CFS)
| 3
|
[
"Do",
"not",
"have",
"fibromyalgia",
"or",
"an",
"associated",
"pain",
"disorder",
",",
"including",
":",
"migraine",
",",
"temporomandibular",
"joint",
"disorder",
"(",
"TMJ",
")",
",",
"chronic",
"pelvic",
"pain",
"(",
"CPP",
")",
",",
"or",
"chronic",
"fatigue",
"syndrome",
"(",
"CFS",
")"
] |
[
0,
0,
0,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02264678
|
22:35:treatment
|
Prior exposure to an ATR inhibitor
| 3
|
[
"Prior",
"exposure",
"to",
"an",
"ATR",
"inhibitor"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT03041441
|
40:50:treatment
|
other condition requiring the need for anxiolysis
| 3
|
[
"other",
"condition",
"requiring",
"the",
"need",
"for",
"anxiolysis"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT02152956
|
1:9:cancer
|
leukemia in 2nd or higher relapse
| 3
|
[
"leukemia",
"in",
"2nd",
"or",
"higher",
"relapse"
] |
[
3,
0,
0,
0,
0,
0
] |
NCT02816736
|
1:10:chronic_disease
|
tamponade
| 3
|
[
"tamponade"
] |
[
2
] |
NCT02236000
|
1:28:treatment,36:72:treatment,83:92:treatment,101:111:cancer
|
Previous therapy with T-DM1 or any HER2 tyrosine kinase inhibitor (TKI) including neratinib for any malignancy
| 3
|
[
"Previous",
"therapy",
"with",
"T-DM1",
"or",
"any",
"HER2",
"tyrosine",
"kinase",
"inhibitor",
"(",
"TKI",
")",
"including",
"neratinib",
"for",
"any",
"malignancy"
] |
[
1,
1,
1,
1,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
0,
3
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.